Inventaire - your friends and communities are your best library

Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective.

author

Giuseppe Felice Mangiatordi

Giovanni Lentini

Orazio Nicolotti

published in: Expert Opinion on Drug Discovery

date of publication: 2017-08-17

language: English

main subject: drug discovery

Cites articles 119

Date

Title

Authors

2017-02-08

Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure
2016-02-12

Innovation in the pharmaceutical industry: New estimates of R&D costs
2016-05-26

Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic Stability
2016-05-19

Ligand Specific Efficiency (LSE) Index for PET Tracer Optimization

David A Sykes, Yves P Auberson
2016-03-14

Improving Drug Design: An Update on Recent Applications of Efficiency Metrics, Strategies for Replacing Problematic Elements, and Compounds in Nontraditional Drug Space
2016-01-01

Recent Trends in the Discovery of Small Molecule Blockers of Sodium Channels

Roberta Gualdani
2016-11-13

The Chemistry and Pharmacology of Citrus Limonoids

Roberta Gualdani, Giovanni Lentini
2016-02-25

Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics

Amedeo Caflisch, Dimitrios Spiliotopoulos, Cristina Nevado
2016-04-07

Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.
2016-01-10

Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI.
2016-10-13

Increased sodium channel use-dependent inhibition by a new potent analogue of tocainide greatly enhances in vivo antimyotonic activity

Annamaria De Luca, Jean-François Desaphy, Sabata Pierno, Diana Conte Camerino, Michela De Bellis
2016-07

CERAPP: Collaborative Estrogen Receptor Activity Prediction Project

Eugene Muratov, Alexander Tropsha, Denis Fourches, Jayaram Kancherla, Kamel Mansouri, Eva B Wedebye, Andrew Worth, Igor V. Tetko, Roberto Todeschini, Christopher M Grulke, Francesca Grisoni, Giuseppe Felice Mangiatordi, Nikolai G Nikolov, Emilio Benfenati, Dragos Horvath, Antony John Williams, Richard S. Judson, Ann M Richard, Huixiao Hong, Marc C Nicklaus, Daniela Trisciuzzi, Orazio Nicolotti
2016-04-08

Design, discovery, modelling, synthesis, and biological evaluation of novel and small, low toxicity s-triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors

Alfonso T. García-Sosa, Maarit Karonen, Andres Merits, Uko Maran
2016-07-19

Benchmarking the Predictive Power of Ligand Efficiency Indices in QSAR

Isidro Cortés-Ciriano
2016-10-21

Debunking the Idea that Ligand Efficiency Indices Are Superior to pIC50 as QSAR Activities
2015-05-01

The $2.6 billion pill--methodologic and policy considerations

Jerry Avorn
2015-09-21

A new paradigm for navigating compound property related drug attrition
2015-04-27

Ligand Binding Thermodynamics in Drug Discovery: Still a Hot Tip?
2015-10-21

Optimization of Inhibitors of Mycobacterium tuberculosis Pantothenate Synthetase Based on Group Efficiency Analysis

Shijun Wen, Tom Blundell
2015-10-06

Docking-based classification models for exploratory toxicology studies on high-quality estrogenic experimental data

Kamel Mansouri, Domenico Alberga, Marco Catto, Saverio Cellamare, Ettore Novellino, Giuseppe Felice Mangiatordi, Emilio Benfenati, Antony John Williams, Richard S. Judson, Daniela Trisciuzzi, Orazio Nicolotti, Angelo Carotti
2015-06-20

Design, synthesis and evaluation of new GEQ derivatives as inhibitors of InhA enzyme and Mycobacterium tuberculosis growth

Giorgia Mori, Frédéric Rodriguez, Maria Rosalia Pasca, Jana Korduláková, Michel Baltas
2015-06-27

Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling

Muhammed Mubarak, Hiba Zalloum, Yasser Bustanji
2015-08-15

Discovery and resupply of pharmacologically active plant-derived natural products: A review

Atanas G. Atanasov, Eva-Maria Pferschy-Wenzig, Thomas Linder, Pavel Uhrin, Veronika Temml, Stefan Schwaiger, Elke Heiss, Judith M Rollinger, Daniela Schuster, Johannes M Breuss, Marko D. Mihovilovic, Rudolf Bauer, Verena Dirsch, Hermann Stuppner, Brigitte Kopp, Christoph Wawrosch, Valery N Bochkov, Birgit Waltenberger
2014-01-19

Finding the rules for successful drug optimisation
2014-02-01

The role of ligand efficiency metrics in drug discovery

Gyorgy M Keseru
2014-08-06

Rational use of plasma protein and tissue binding data in drug design
2014-04-01

Alternative variables in drug discovery: promises and challenges
2014-03-07

N-aryl-2,6-dimethylbenzamides, a new generation of tocainide analogues as blockers of skeletal muscle voltage-gated sodium channels

Alessia Catalano, Alessia Carocci, Carlo Franchini, Antonio Carrieri, Annamaria De Luca, Michela De Bellis, Filomena Corbo, Diana Conte Camerino, Jean-François Desaphy
2014-07-03

REACH and in silico methods: an attractive opportunity for medicinal chemists

Orazio Nicolotti, Ettore Novellino, Giuseppe Felice Mangiatordi, Emilio Benfenati, Domenico Gadaleta, Angelo Carotti
2014-09-22

Ligand efficiency-based support vector regression models for predicting bioactivities of ligands to drug target proteins
2014-04-10

Curing chronic hepatitis C--the arc of a medical triumph

Raymond T Chung, Thomas F Baumert
2014-04-05

Hot spot-based design of small-molecule inhibitors for protein-protein interactions

Haitao (mark) Ji

Article - wd:Q50502203

Welcome to Inventaire

the library of your friends and communities

learn more